Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world post-marketing re-evaluation of Xiaoerfeireqing Granules in children with acute bronchitis
ChiCTR1900023802Phase 4Not yet recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of xiaoerfeireqing in acute bronchitis, sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Total effective rate of disease, Single symptom and sign disappearance rate and 1 more. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
xiaoerfeireqing
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on ChiCTR1900023802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023802.